LANSING, Mich., April 10, 2012 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB.PK) (the "Company") announces that researchers working with the Company have performed approximately five thousand zinc finger nuclease assisted micro-insertions during the past two weeks. The genetic insertions were performed in five separate and unique batches of approximately one thousand insertions per round.
"Given the targeting efficiency of the zinc finger nuclease technology and the knowledge base we developed, it is highly probable that these five rounds will produce multiple transgenics," said Company CEO, Kim Thompson. "Each of these five rounds is distinctive in terms of the genetic sequences that were used or based on some other special attribute of the genetic insertion protocol."
"From my perspective," continued Thompson, "these five thousand insertions, performed by a very distinguished group of researchers at the University of Notre Dame, consist of our most recent configurations and are the most exciting and promising to date. Each of these insertions was tailored with one goal in mind, the creation of our generation two, advanced spider silk polymer. Indeed, each round of genetic engineering insertions has the potential to create a new recombinant spider silk fiber with commercial applications."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.